Eli Lilly and Company (NYSE: LLY) today announced the pricing of its first sustainability bond to advance its global environmental, social and governance (ESG) strategy to extend access to medicines, improve lives and communities, empower a various workforce, minimize environmental impact and operate ethically and responsibly. the corporate is issuing €600 million in aggregate principal amount of 0.50% notes with 12-year maturity, subject to customary closing conditions.
“Lilly is taking another breakthrough in advancing our purpose of creating life better for people round the world,” said Anat Ashkenazi, Lilly’s chief treasurer . “This sustainability bond is Lilly’s latest commitment to our ESG strategy, which is core to our mission.”
In line with its newly introduced Sustainability Bond Framework, Lilly intends to allocate an amount like internet proceeds from the sustainability bond to eligible projects designed to advance one or more of the subsequent ESG objectives:
Increase Access to Medicines
Provide free or subsidized health care and treatment options to people with limited resources, including those that sleep in low and middle-income countries, or those suffering from socioeconomic crises like the COVID-19 pandemic.
Improve Lives and Communities/Empower a various Workforce
Recruit, hire and train a various workforce and increase procurement of products and services from diverse suppliers, including companies owned by women, ethnic and racial minorities and members of the LGBTQ community.
Minimize Environmental Impact
Reduce air emissions by improving energy efficiency – through the planning , construction, operation, or maintenance of energy-efficient equipment, facilities and infrastructure – also as increasing renewable energy capacity through the acquisition or development of latest onsite or offsite renewable energy technology.
Reduce waste and water emissions, improve water quality and efficiency and protect coastal, marine and watershed environments.
Sustainalytics, a number one global provider of environmental, social and company governance research and ratings, reviewed Lilly’s Sustainability Bond Framework and provided a positive second party opinion. The Sustainability Bond Framework is aligned with the Sustainability Bond Guidelines 2021, Green Bond Principles 2021 and Social Bond Principles 2021.
Additional information on Lilly’s comprehensive ESG strategy, goals and progress are often found at esg.lilly.com.
About Eli Lilly and Company
Lilly may be a global health care leader that unites caring with discovery to make medicines that make life better for people round the world. We were founded quite a century ago by a person committed to making high-quality medicines that meet real needs, and today we remain faithful that mission altogether our work. Across the world , Lilly employees work to get and convey life-changing medicines to those that need them, improve the understanding and management of disease, and provides back to communities through philanthropy and volunteerism. to find out more about Lilly, please visit us at lilly.com and lilly.com/news. I-LLY
Lilly Cautionary Statement Regarding Forward-Looking Statements
This handout contains forward-looking statements (as that term is defined within the Private Securities Litigation Reform Act of 1995) about the offering of sustainability bonds, including our sustainability objectives, goals and commitments, and reflects Lilly’s current beliefs and expectations. However, like any such undertaking, there are substantial risks and uncertainties that would impact Lilly’s ability to finish the offering of sustainability bonds on favorable terms, if at all, including general market conditions that would affect the offering of sustainability bonds and other risks and uncertainties, many of which are beyond Lilly’s control, that would cause its actual results to differ materially from those indicated in its forward-looking statements. For further discussion of those and other risks and uncertainties, see Lilly’s latest Forms 10-K, 10-Q and any 8-Ks filed with the us Securities and Exchange Commission. Except as needed by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.
Source link: https://investor.lilly.com/
